The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease

Bibliographic Details
Main Author: Mario Cazzola
Format: Article
Language:English
Published: SAGE Publishing 2010-08-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/1753465810377636